GPI-15715 (PQ-1002): Began Phase I trial

Guilford Pharmaceuticals Inc. (GLFD), Baltimore, Md.
Product:

Read the full 71 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE